CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 121 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06482125
NCT06482125N/ACompleted
CompareCT.gov

Emergence Agitation in Pediatrics After Dexmedetomidine vs. Sevoflurane Anesthesia: a Randomized Controlled Trial

Pelita Harapan University·interventional·Posted Jul 1, 2024·Updated May 28, 2025

In Brief

A clinical study evaluating Dexmedetomidine and Sevoflurane for Emergence Delirium. Completed, enrolled 121 participants across 1 site.

Detailed Summary

Emergence agitation is commonly encountered after receiving inhalation anesthesia. This distressing phenomenon carries risks that are harmful to patients, caregivers and medical personnel. Using total intravenous Dexmedetomidine, the investigators seek to reduce agitation and provide gentle emergence from anesthesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEmergence Delirium
CountriesIndonesia
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedJul 1, 2024
Enrollment StartJul 31, 2024
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.0 years ago

Interventions

Dexmedetomidinedrug

Intervention group will receive Total Intravenous Dexmedetomidine as their anesthetic maintenance agent. Intravenous Dexmedetomidine 1.5ug/kg will be administered within 10 minutes and maintenance dose of 1.5ug/kg/hour continued as the sole anesthetic maintenance agent, thereafter.

Sevofluranedrug

Inhalation Sevoflurane will be administered as an anesthetic maintenance agent. Sevoflurane at 2 - 3 Vol% will be administered throughout the operative procedure.